NEUROSURGERY, cilt.51, sa.5, ss.1246-1254, 2002 (SCI İndekslerine Giren Dergi)
OBJECTIVE: Immunostaining for p53 commonly is considered a marker of neoplasia. Previous studies of nonneoplastic processes have yielded conflicting results.